Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX
· Real-Time Price · USD
1.37
-0.02 (-1.44%)
At close: Oct 09, 2025, 10:58 AM
-1.44% (1D)
| Bid | 1.36 |
| Market Cap | 31.92M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -53.31M |
| EPS (ttm) | -2.91 |
| PE Ratio (ttm) | -0.47 |
| Forward PE | -1.78 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1.48 |
| Volume | 70,671 |
| Avg. Volume (20D) | 135,603 |
| Open | 1.39 |
| Previous Close | 1.39 |
| Day's Range | 1.33 - 1.39 |
| 52-Week Range | 1.04 - 4.40 |
| Beta | 1.14 |
| Ex-Dividend Date | n/a |
About RNTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RNTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RNTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+1.03%
Rein Therapeutics shares are trading lower after t...
Unlock content with
Pro Subscription
